Close Menu

Personal Genome Diagnostics

NEW YORK (GenomeWeb News) – Cancer genome analysis firm Personal Genome Diagnostics said today that it will collaborate with Blueprint Medicines to search for novel kinase targets for cancer drugs.

NEW YORK (GenomeWeb News) – Cancer genetic analysis firm Personal Genome Diagnostics today announced it has licensed the exclusive rights to the Digital Karyotyping genome mapping technology from Johns Hopkins University.

Following last month's publication of a study that suggested the Papanicolaou test, or Pap smear, could potentially be repurposed as a sequencing-based screening test for endometrial and ovarian cancer, the authors are now working on validating the results, hoping to develop a ro

Researchers at Johns Hopkins University who helped pioneer cancer genome sequencing have launched a commercial effort intended to translate their experience into clinical care.

Pages

A letter criticizing actions by the US government and research institutions toward Chinese and Chinese-American scientists has garnered more than a hundred signatories.

NPR reports that researchers in New York are investigating whether it is possible to edit the genomes of human sperm.

In an opinion piece at the Nation, Sarah Lawrence College's Laura Hercher argues that everyone should be able to access prenatal genetic testing.

In Nature this week: ancient DNA uncovers presence of Mediterranean migrants at a Himalayan lake, and more.